Abeta toxicity 2 - Masters, Colin L. (Henry Stewart Talks, 2011)
The Australian imaging, biomarkers and lifestyle (aibl) flagship study of ageing, Methodology: key outcomes, Abeta and amyloid imaging, The progression of AD, Abeta and memory, Prediction of conversion from HC to MCI/AD, Impact of amyloid imaging in MCI patient selection for anti-amyloid therapeutic trials, Longitudinal PiB PET follow-up, Plasma Abeta 42 levels in the PiB-PET AIBL subset, Relation between Abeta oligomers in blood cellular elements, cognition and PiB SUVR, Plasma ApoE (total) levels: the AIBL study, Biomarker discovery, Abeta deposition